Medacta Group SA

MOVE · SW · Healthcare / Medical Devices

108.00CHF-0.60 (-0.55%)

Price History

Full chart

Market Stats

Previous Close108.60

Open108.80

Day Range107.00 – 109.00

52-Week Range107.40 – 175.84

Volume57.57K

Market Cap2.29B

P/E (TTM)31.66

Forward P/E30.77

EPS3.62

Dividend Yield0.96%

Beta1.01

50-Day Avg123.68

200-Day Avg142.66

About

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Company Details

SectorHealthcare
IndustryMedical Devices
CEODr. Francesco Siccardi
Employees2.27K
HeadquartersStrada Regina, 34, Castel San Pietro, Switzerland, 6874, Switzerland
Websitehttps://www.medacta.com

Leadership

Dr. Alberto SiccardiFounder & Non Executive Chairman · b. 1944
Dr. Francesco SiccardiChief Executive Officer · b. 1977
Mr. Corrado FarsettaChief Financial Officer · b. 1968
Mr. Asif HussainChief People Officer · b. 1971
Mr. Alessandro SiccardiChief Supply Chain Officer · b. 1986
Filippo CappelliHead of IT
Mr. Giovanni Niccolo GalliChief Commercial Officer · b. 1976
Mr. Massimiliano BernardoniChief Innovation Officer · b. 1973
Donato CortesiSecretary of the Board
Antonio Di BrinoGroup Vice President of Finance & Tax

Financials

Income Statement

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	219.05M	244.68M	272.61M	310.62M	302.49M	363.13M	437.12M	510.78M	590.58M	688.27M
Growth (%)	-	+11.70%	+11.41%	+13.94%	-2.62%	+20.04%	+20.38%	+16.85%	+15.62%	+16.54%
Cost of Revenue	54.50M	62.08M	68.63M	86.93M	88.24M	101.88M	131.87M	162.93M	191.14M	246.89M
Gross Profit	164.55M	182.60M	203.98M	223.70M	214.26M	261.25M	305.26M	347.85M	399.44M	441.40M
Gross Margin	75.12%	74.63%	74.82%	72.02%	70.83%	71.94%	69.83%	68.10%	67.64%	64.13%
Operating Expense	115.06M	132.94M	142.47M	183.60M	164.81M	202.47M	243.79M	273.40M	308.61M	325.75M
Operating Income	49.49M	49.66M	61.51M	40.09M	49.44M	58.78M	61.46M	74.44M	90.83M	115.65M
Operating Margin	22.60%	20.30%	22.56%	12.91%	16.35%	16.19%	14.06%	14.57%	15.38%	16.80%
EBITDA	68.53M	71.42M	84.98M	73.83M	81.96M	97.81M	106.96M	119.64M	160.51M	190.55M
EBITDA Margin	31.29%	29.19%	31.17%	23.77%	27.09%	26.94%	24.47%	23.42%	27.18%	27.69%
Net Income	39.22M	33.50M	45.75M	11.86M	37.09M	51.52M	46.25M	47.36M	72.89M	96.12M
Net Income Margin	17.90%	13.69%	16.78%	3.82%	12.26%	14.19%	10.58%	9.27%	12.34%	13.97%
R&D	3.11M	3.48M	3.93M	7.64M	6.83M	11.31M	16.22M	20.32M	21.39M	12.97M
R&D as % of Total Revenue	1.42%	1.42%	1.44%	2.46%	2.26%	3.11%	3.71%	3.98%	3.62%	1.88%
Interest Expense	1.19M	1.69M	2.10M	3.36M	3.04M	3.44M	3.66M	6.83M	7.51M	6.85M
Interest Expense % of Total Revenue	0.54%	0.69%	0.77%	1.08%	1.01%	0.95%	0.84%	1.34%	1.27%	1.00%

Balance Sheet

Currency: EUR	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	218.84M	269.68M	299.81M	365.60M	412.56M	441.94M	489.27M	584.49M	695.87M	792.18M	916.93M
Total Liabilities	110.29M	122.81M	198.14M	276.53M	289.33M	277.22M	262.87M	309.83M	365.83M	412.51M	460.71M
Total Equity	108.55M	146.87M	101.67M	89.07M	123.23M	164.72M	226.40M	274.65M	330.04M	379.66M	456.22M
Cash	7.28M	20.70M	25.12M	33.71M	27.24M	48.07M	20.40M	32.26M	20.79M	31.59M	33.19M
Total Debt	41.29M	41.17M	97.62M	162.88M	152.15M	150.00M	132.66M	170.25M	201.98M	241.21M	262.56M
Net Debt	34.01M	20.47M	72.50M	129.17M	124.91M	101.93M	112.26M	137.99M	181.19M	209.62M	229.38M

Cash Flow

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	56.31M	51.59M	66.41M	42.63M	59.59M	54.06M	73.51M	75.13M	107.14M	153.65M
Investing Cash Flow	-33.75M	-44.94M	-49.22M	-42.04M	-34.19M	-52.04M	-65.11M	-80.61M	-98.87M	-137.86M
Financing Cash Flow	-9.10M	-1.03M	-9.52M	-10.98M	-6.03M	-31.21M	3.44M	-10.13M	4.33M	-18.91M
Capital Expenditure	28.29M	40.11M	55.13M	41.47M	27.29M	46.49M	63.16M	82.22M	104.69M	123.75M
Free Cash Flow	28.02M	11.47M	11.28M	1.16M	32.31M	7.57M	10.35M	-7.09M	2.45M	29.90M
Dividends Paid	62.81M	62.81M	65.25M	10.42M	10.42M	10.42M	10.42M	11.05M	11.19M	14.76M
FCF to OCF	49.76%	22.24%	16.98%	2.72%	54.21%	14.00%	14.08%	-9.44%	2.29%	19.46%
Dividend Paid to FCF	224.15%	547.39%	578.69%	897.33%	32.25%	137.62%	100.64%	-155.84%	456.53%	49.36%

Earnings

Report Date	Sep 7, 2020	Mar 31, 2021	Sep 10, 2021	Mar 11, 2022	Sep 9, 2022	Mar 17, 2023	Mar 25, 2025	Sep 8, 2025	Dec 31, 2025	Sep 9, 2026	Mar 10, 2027
EPS Estimate	0.00	0.00	0.00	-	0.00	0.00	0.00	-	-	-	-
EPS Actual	0.00	0.00	1.61	1.61	0.00	0.00	1.75	3.01	1.76	-	-
Surprise	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	Pre-market	After-hours	Pre-market	-	After-hours	-	After-hours	Pre-market

Key Statistics & Ratios

Market Cap2.29B

Enterprise Value2.54B

Trailing P/E31.66

Forward P/E30.77

Price / Sales3.23

Price / Book5.00

EPS3.62

Book Value22.93

Revenue (TTM)707.85M

Gross Profit (TTM)463.70M

EBITDA170.52M

Profit Margin10.92%

Operating Margin14.95%

Return on Equity17.03%

Return on Assets7.19%

Shares Outstanding19.95M

Shares Float6.03M

Beta1.01

Dividend Yield0.96%

Dividend Rate1.10

Payout Ratio62.39%

Dividends

20261×

1.10May 7, 2026

20251×

0.69May 9, 2025

20241×

0.55May 10, 2024

20231×

0.27May 2, 2023

20221×

0.54May 23, 2022